Prosecution Insights
Last updated: October 27, 2026

Centre National de la Recherche Scientifique

Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials

61 pending office actions • 48 art units • 59 examiners • 1 of 61 (2%) have an AI response strategy ready • 71 patents granted in the last 365 days

Analysis

Centre National de la Recherche Scientifique has 61 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 59 distinct examiners and 47 distinct art units, showing broad distribution across the examining corps and technical organization. The difference between examiner and art-unit counts indicates that some art units handle more than one matter, while examiner overlap remains limited.

MELLOTT, JAMES M is the busiest examiner, with 2 pending matters. No single examiner appears to control a substantial share of the active docket. Counsel may therefore benefit from matter-specific prosecution strategies, especially where the portfolio spans varied biotechnology and pharmaceutical subject matter.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

61
Total Pending OAs
49
Non-Final OAs
10
Final Rejections
2
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 12 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

3
Overdue
2
Due this week
6
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 12 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (3)Due ≤ 7 days (2)Due ≤ 30 days (6)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

42
Hard (69%)
11
Medium (18%)
7
Easy (11%)
1
Unknown (2%)

Rejection Statute Mix

BucketCases
§101 only2 (3%)
§101 + other5 (8%)
§103 only9 (15%)
§102 only1 (2%)
§112 only7 (11%)
Double-patenting + other1 (2%)
Multi-statute (no §101)35 (57%)
No statute on record1 (2%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

42
Life Sciences
69% of docket
2
Information Tech
3% of docket
1
Communications
2% of docket
6
Semiconductors
10% of docket
9
Mechanical / Eng
15% of docket
1
Business / Other
2% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

610 h
Manual time on pending OAs
122 h
Time saved (low, 20%)
214 h
Time saved (mid, 35%)
5.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MELLOTT, JAMES M 2 51.1% +44.1%
MEYERING, SHABANA SHABBEER 2 68.5% +45.1%
ENDRESEN, KIRSTEN DANIELA 1 70.7% +17.5%
ALHWAMDEH, KAREEM FUAD 1 100.0% +0.0%
MENDOZA, ALEXANDRIA ARELLANO 1 68.8% +28.0%
AHVAZI, BIJAN 1 63.1% +47.6%
BRANCH, CATHERINE S 1 85.7% +3.5%
BUI PHO, PASCAL M 1 63.6% -18.7%
LANKFORD JR, LEON B 1 70.0% +31.5%
NGUYEN, TUAN HOANG 1 90.5% +4.0%

Hard Cases (42)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17628938 IRON AND COBALT MOLECULAR COMPLEXES FOR THE SELECTIVE ELECTROCHEMICAL REDUCTION OF CO2 INTO CO, WITH FLOW CELLS VAN, LUAN V 38d overdue
18247001 SYSTEM AND METHOD FOR SUPPRESSING LOW FREQUENCY MAGNETIC NOISE IN MAGNETO-RESISTIVE SENSORS SCHINDLER, DAVID M 23d overdue
18516616 VARIANTS OF A DNA POLYMERASE OF THE POLX FAMILY YAMASAKI, ROBERT J 8d
18020045 NEUROMUSCULAR CHARACTERISATION METHOD AND ASSOCIATED MEASURING BENCH TU, AURELIE H 16d
18082711 METHOD FOR ASSEMBLING A ZIRCONIA PART TO A TITANIUM ELEMENT PATEL, DEVANG R 33d
19423243 PHASE-CHANGE MATERIAL SWITCH ENDRESEN, KIRSTEN DANIELA —
19108191 FAULT TOLERANT PREPARATION OF QUANTUM POLAR CODES ALHWAMDEH, KAREEM FUAD —
19100510 DEFLECTOMETRY METHOD AND ASSOCIATED SYSTEM MENDOZA, ALEXANDRIA ARELLANO —

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17597351 METHODS FOR THE TREATMENT OF EPILEPSY MEYERING, SHABANA SHABBEER 5d
18866108 CAPACITIVELY COUPLED PLASMA-ENHANCED ATOMIC LAYER DEPOSITION METHOD MELLOTT, JAMES M 6d
17810022 METHODS FOR THE TREATMENT OF EPILEPSY MEYERING, SHABANA SHABBEER 21d
19423243 PHASE-CHANGE MATERIAL SWITCH ENDRESEN, KIRSTEN DANIELA —
19100510 DEFLECTOMETRY METHOD AND ASSOCIATED SYSTEM MENDOZA, ALEXANDRIA ARELLANO —
18879608 Composite solar-control coating based on tungsten bronze nanocrystals dispersed in a silica-based sol-gel matrix AHVAZI, BIJAN —
18866416 PLASMA-ENHANCED DEPOSITION REACTOR MELLOTT, JAMES M —
18863011 BACTERIAL MYELOPEROXIDASE-CATALASE AND APPLICATIONS THEREOF LANKFORD JR, LEON B —

Top Art Units

Art UnitApps
1759 3
1634 3
1762 3
3798 2
1657 2
1621 2
1612 2
1632 2
1635 2
2874 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19423243 PHASE-CHANGE MATERIAL SWITCH ENDRESEN, KIRSTEN DANIELA 2874 §103§112 Non-Final OA — Pending Dec 17, 2025
19108191 FAULT TOLERANT PREPARATION OF QUANTUM POLAR CODES ALHWAMDEH, KAREEM FUAD 2112 §101 Non-Final OA — Pending Mar 03, 2025
19100510 DEFLECTOMETRY METHOD AND ASSOCIATED SYSTEM MENDOZA, ALEXANDRIA ARELLANO 2877 §103§112 Non-Final OA — Pending Jan 31, 2025
18879608 Composite solar-control coating based on tungsten bronze nanocrystals dispersed in a silica-based sol-gel matrix AHVAZI, BIJAN 1712 §102§103§112Other Non-Final OA — Pending Dec 27, 2024
18867873 COMPOSITION BASED ON (METH)ACRYLATE COMPOUNDS BRANCH, CATHERINE S 1746 §102§103§112 Non-Final OA — Pending Nov 21, 2024
18954009 SYSTEM AND METHOD FOR RECONSTRUCTING A PHYSIOLOGICAL SIGNAL OF AN ARTERY/TISSUE/VEIN DYNAMIC SYSTEM OF AN ORGAN IN A SURFACE SPACE BUI PHO, PASCAL M 3798 §101§103§112 Non-Final OA — Pending Nov 20, 2024
18866108 CAPACITIVELY COUPLED PLASMA-ENHANCED ATOMIC LAYER DEPOSITION METHOD MELLOTT, JAMES M 1759 §103DP Final Rejection 6d Pending Nov 15, 2024
18866416 PLASMA-ENHANCED DEPOSITION REACTOR MELLOTT, JAMES M 1759 §103 Non-Final OA — Pending Nov 15, 2024
18863011 BACTERIAL MYELOPEROXIDASE-CATALASE AND APPLICATIONS THEREOF LANKFORD JR, LEON B 1657 §102§103 Non-Final OA — Pending Nov 05, 2024
18931810 METHOD OF CONTROLLING THE OBSERVATION OF A SPACE USING A TRACKING SYSTEM AND ASSOCIATED DEVICE NGUYEN, TUAN HOANG 2649 §102§112 Non-Final OA — Pending Oct 30, 2024
18860222 AMYLOID FIBER-BASED ELECTRICITY GENERATOR GONZALEZ QUINONES, JOSE A 2834 §103§112 Non-Final OA — Pending Oct 25, 2024
18856605 COMPOSITIONS OF DISPERSED SYSTEMS FOR BIOMEDICAL APPLICATIONS, PROCESS FOR THEIR PREPARATION AND USES THEREOF LIPPERT, JOHN WILLIAM — §101§103§112 Non-Final OA — Pending Oct 11, 2024
18897766 SPECIFIC TETRADENTATE COPPER CHELATORS AS ANTICANCER AGENTS KIM, SEONG JONG 1621 §103§112 Non-Final OA — Pending Sep 26, 2024
18849747 METHOD FOR PRESERVING CELLS CONNORS, ALEXANDRA F 1634 §102§103§112 Non-Final OA — Pending Sep 23, 2024
18840176 HETEROGENEOUS PALLETISATION METHOD AND SYSTEM BROTHERS, LAURENCE RAPHAEL 3655 §102§103§112 Non-Final OA — Pending Aug 21, 2024
18834371 TWO-DIMENSIONAL ELECTRON GAS FIELD-EFFECT TRANSISTOR HAVING SIDE GATES ENAD, CHRISTINE A 2811 §103 Non-Final OA — Pending Jul 30, 2024
18832826 NOVEL AQUEOUS-PHASE REDOX FLOW BATTERIES BERNATZ, KEVIN M 1725 §103§112 Non-Final OA — Pending Jul 24, 2024
18730421 GLYCOSYL BARBITURATE-BASED GELLING AGENTS PACKARD, BENJAMIN J 1612 §102§103 Non-Final OA — Pending Jul 19, 2024
18724773 NOVEL BISPIDINE-BASED METAL CHELATING LIGANDS DISPLAYING GOOD RELAXIVITY LEWOCZKO, EVAN MICHAEL 1612 §103§112 Non-Final OA — Pending Jun 27, 2024
18721781 BENZENE SULFONAMIDE THIAZOLE COMPOUNDS AND THEIR USE FOR THE TREATMENT OF CANCERS CHICKS, ASHLI ARIANA 1626 §112 Final Rejection — Pending Jun 19, 2024
18720854 METHOD FOR PRODUCING A FERMENTED GRAPE MARC, RESULTING FERMENTED GRAPE MARC AND USE THEREOF IN DIETARY SUPPLEMENTS OR IN COSMECEUTICALS KOHLER, STEPHANIE A 1793 §103§112 Non-Final OA — Pending Jun 17, 2024
18720548 USE OF BISAMIDE COMPOUNDS TO IMPROVE THE AGEING RESISTANCE OF BITUMEN GUINO-O UZZLE, MARITES A 1731 §103§112 Non-Final OA — Pending Jun 14, 2024
18717851 Method of Production of Organoids and Uses Thereof CANDELARIA, JULIANA IRENE 1634 §103§112 Non-Final OA — Pending Jun 07, 2024
18715351 DEVICE FOR LOADING AND PUSHING RADIOACTIVE SEEDS YANG, YI-SHAN 3798 §103§112 Non-Final OA — Pending May 31, 2024
18709695 IRAP INHIBITORS FOR USE IN THE TREATMENT OF INFLAMMATORY DISEASES ONDACHI, PAULINE WANJIKU MUCH 1627 §102§103§112 Non-Final OA — Pending May 13, 2024
18702930 DUAL CATALYST COMPOSITIONS HUHN, RICHARD A 1764 §112 Non-Final OA — Pending Apr 19, 2024
18699818 DEVICE AND METHOD FOR NEAR REAL-TIME PREDICTION OF AN IRRADIATION MAP FOR INTERVENTIONAL RADIOLOGY MOHAMMED, SHAHDEEP 3797 §101§102§112 Non-Final OA — Pending Apr 09, 2024
18691769 BET INHIBITORS FOR TREATING PAB1 DEFICIENT CANCER O DELL, DAVID K 1621 §102§103 Final Rejection — Pending Mar 13, 2024
18688894 METHOD FOR SYNTHESISING COLLOIDAL SUSPENSIONS OF NANORODS EDMONDSON, LYNNE RENEE 1734 §103§112 Non-Final OA — Pending Mar 04, 2024
18685591 PRODUCTION OF CELLULAR PRODUCTS BY CELLS EMBEDDED IN A HYDROGEL MATRIX NICOL, ALEXANDER W 1634 §102§112 Non-Final OA — Pending Feb 22, 2024
18685660 METHODS FOR PRODUCTION OF ENGINEERED CELLS STAVROU, CONSTANTINA E 1632 §102§103§112 Non-Final OA — Pending Feb 22, 2024
18293303 THIONOLACTONES, PROCESSES OF SYNTHESIS, USES AS COMONOMERS AND FOR POLYMER FUNCTIONALIZATION AND DEGRADATION YOON, TAE H 1762 §102§112 Non-Final OA — Pending Jan 29, 2024
18577707 METHOD FOR OPTICAL WRITING IN A SEMICONDUCTOR MATERIAL, CORRESPONDING COMPUTER PROGRAM PRODUCT, STORING MEDIUM AND WRITING DEVICE PARK, JE HWAN JOHN 3761 §103§112 Non-Final OA — Pending Jan 09, 2024
18577082 COMPUTERIZED METHOD FOR AUDIOVISUAL DELINEARIZATION SALCE, JASON P 2421 §112 Non-Final OA — Pending Jan 05, 2024
18576182 COMPOSITION BASED ON (METH)ACRYLATE MONOMERS TESKIN, FRED M 1762 §103§112Other Non-Final OA — Pending Jan 03, 2024
18576224 COMPOSITION BASED ON (METH)ACRYLATE MONOMERS LEE, RIP A 1762 — Non-Final OA — Pending Jan 03, 2024
18575587 PANCREATIC CELL RECEIVING MATRIX AND IMPROVED ARTIFICIAL PANCREAS DEVICE FLORES, ADRIAN 3774 §101§102§103 Non-Final OA — Pending Dec 29, 2023
18568521 USE OF CASD1 AS A BIOMARKER OF A CANCER EXPRESSING THE O-ACETYLATED-GD2 GANGLIOSIDE VANN-OJUEKAIYE, KENDRA RAYCHELL 1682 §103§112Other Non-Final OA — Pending Dec 08, 2023
18516616 VARIANTS OF A DNA POLYMERASE OF THE POLX FAMILY YAMASAKI, ROBERT J 1657 §103§112 Final Rejection 8d Pending Nov 21, 2023
18558590 OXYFLUORIDES, ELECTRODES CONTAINING THEM AND THEIR USE FOR HYDROGEN PRODUCTION RUMP, RICHARD M 1759 §112 Non-Final OA — Pending Nov 02, 2023
18286252 FOLR2+ MACROPHAGES AND ANTI-TUMOR IMMUNITY CHATTIN, AMY MARIE 1643 §101§102§103§112 Non-Final OA — Pending Oct 10, 2023
18551899 SYSTEM AND METHOD FOR IMAGING IN THE OPTICAL DOMAIN HELLNER, MARK 3645 §103 Non-Final OA — Pending Sep 22, 2023
18462100 MIXING DEVICE WITH CIRCULATION ZONE AND ASSOCIATED METHOD BHATIA, ANSHU 1774 §102§103 Non-Final OA — Pending Sep 06, 2023
18260902 METHOD FOR SPATIAL MAPPING AND SEQUENCING OF CELLS OR ORGANELLES TSUI, YUNG-SHENG M 1743 §102 Non-Final OA — Pending Jul 10, 2023
18128388 POSITIVE ELECTRODE ACTIVE MATERIAL, PREPARATION METHOD THEREOF, AND POSITIVE ELECTRODE CARRICO, ROBERT SCOTT 1727 §103 Non-Final OA — Pending Mar 30, 2023
18247001 SYSTEM AND METHOD FOR SUPPRESSING LOW FREQUENCY MAGNETIC NOISE IN MAGNETO-RESISTIVE SENSORS SCHINDLER, DAVID M 2858 §102§103 Final Rejection 23d overdue Pending Mar 28, 2023
18020045 NEUROMUSCULAR CHARACTERISATION METHOD AND ASSOCIATED MEASURING BENCH TU, AURELIE H 3791 §101 Final Rejection 16d Pending Feb 06, 2023
18084934 METHODS FOR DETERMINING THE CONVERSION FACTOR BETWEEN THE VOLTAGE APPLIED TO A SYSTEM AND A PARAMETER OF SAID SYSTEM, THE OSCILLATION PERIOD BETWEEN TWO SPIN STATES AND THE EXCHANGE INTERACTION BETWEEN TWO CHARGED PARTICLES AND SYSTEM THEREFOR PATERSON, BRIGITTE A 2896 §112 Non-Final OA 12d Pending Dec 20, 2022
18082711 METHOD FOR ASSEMBLING A ZIRCONIA PART TO A TITANIUM ELEMENT PATEL, DEVANG R 1735 §103§112 Non-Final OA 33d Pending Dec 16, 2022
17925328 METHODS FOR THE DIAGNOSIS AND TREATMENT OF CYTOKINE RELEASE SYNDROME HUDSON, AMY ROSE 1636 §103§112 Non-Final OA — Pending Nov 15, 2022

View all 61 →

Managing Centre National de la Recherche Scientifique's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Centre National de la Recherche Scientifique have?

Centre National de la Recherche Scientifique has 61 pending office actions as of October 2026, spread across 48 art units and 59 examiners.

Which USPTO examiner handles the most Centre National de la Recherche Scientifique applications?

James M Mellott has the most, with 2 of Centre National de la Recherche Scientifique's pending office actions.

What technology area are Centre National de la Recherche Scientifique's patent applications in?

Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month